Clinical Trial Update: Markers of Favorable Response to FcRn Inhibitors(INFORM)

View source ↗

Summary

This update describes the INFORM study investigating biomarkers of favorable response to FcRn inhibitors in generalized myasthenia gravis and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis Generalized

Drugs mentioned

• FcRn inhibitors

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Myasthenia Gravis Generalized | Status: RECRUITING